Abstract:Objective:To explore the value of automated cardiac motion quantification (aCMQ) in evaluating left ventricular systolic function in uremia patients with different durations of dialysis.Methods:Fifty-two cases of uremia were selected at First People's Hospital of Xiaoshan District from May 2018 to February 2019. They were divided into three groups according to the duration of hemodialysis. Group A consisted of 27 patients receiving dialysis for ≤ 3 years, group B consisted of 16 patients receiving dialysis for ＞ 3 years to less than 7 years, and group C consisted of 9 patients receiving dialysis for ＞ 7 years. A normal control group consisting of 60 subjects with no past history of heart and kidney disease was also included. M echocardiography was performed to estimate the left ventricular ejection fraction (LVEF) using the Teichholz method, and the X-Plane technique was used to collect four- and two-chamber view images of the heart for four cardiac cycles. Left ventricular end-diastole and left ventricular end-systole were recorded according to electrocardiogram, and the LVEF of the case group and control group was calculated by double plane Simpson method. The aCMQ was used to obtain left ventricular global longitudinal strain (LVGLS). Longitudinal strain of the left ventricle in apical four-chamber view, two-chamber view, and three-chamber view (LVAP4LS, LVAP2LS, and LVAP3LS) was obtained by aCMQ to analyze the changes of left ventricular long axis strain in uremia patients with different durations of dialysis. Analysis of variance was used for comparison among groups, and LSD-t test was used for pairwise comparison between groups.Results:The mean LVEF measured by the Teichholz method was (67.21±6.63)% in group A, (64.73±6.47)% in group B, (64.58±8.38)% in group C, and (67.02±3.62)% in control group. The mean LVEF measured by Simpson method was (64.71±4.93)% in group A, (64.08±6.02)% in group B, (63.91±7.49)% in group C, and (66.17±3.14)% in control group. There was no significant difference in LVEF between the case groups or between the case group and control group (P＞0.05 for all). The mean values of LVGLS measured by aCMQ were (-20.79±2.70)%, (-20.03±3.58)%, (-18.32±3.71)%, and (-24.39±2.05)% in groups A, B, C, and control group, respectively. The mean values of LVAP4LS during the systolic period were as follows: group A (-22.09±2.76)%, group B (-20.11±3.94)%, group C (-19.49±3.73)%, and control group (-24.61±2.37)%. The mean values of LVAP3LS during the systolic period were as follows: group A (-19.32±3.85)%, group B (-19.28±4.37)%, group C (-16.61±4.40)%, and control group (-23.53±6.18)%. The mean values of LVAP2LS during the systolic period were as follows: group A (-20.09±2.53)%, group B (-19.57±2.65)%, group C (-18.09±4.01%), and control group (-23.51±7.52)%. LVGLS, LVAP4LS, LVAP2LS, and LVAP3LS were significantly reduced in the case groups compared to the control group (group A vs control group: t=-5.949, -3.844, -6.117, and -4.863, P＜0.001 for all; group B vs control group: t=-5.883, -5.619, -5.036, and -4.650, P＜0.001 for all; group C vs control group: t=-6.541, -5.081, -6.130, and -4.854, P＜0.001 for all). The LVGLS, LVAP4LS, and LVAP3LS values of group A were significantly lower than those of group C (t=-2.493, -2.405, and -2.012; P=0.014, 0.018, and 0.047, respectively). The LVAP2LS value did not differ significantly between group A and group B or group C (P＞0.05), and between group B and group C (P＞0.05).Conclusion:aCMQ can evaluate the abnormality of left ventricular systolic function in uremia patients with different durations of dialysis, which provides a new way for early prevention and treatment of heart failure.

Assessment of Cardiac Structure and Function by Ultrasound in Diabetic Nephropathy Patients Starting Peritoneal Dialysis

Assessment of Real-Time Three-Dimensional Echocardiography As a Tool for Evaluating Left Atrial Volume and Function in Patients with Type 2 Diabetes Mellitus.

Left Ventricular Myocardial Function in Hemodialysis and Nondialysis Uremia Patients: a Three-Dimensional Speckle-Tracking Echocardiography Study.

Preliminary Study of Three-Dimensional Speckle Tracking Echocardiography in Evaluation of Left Ventricular Systolic Longitudinal Strain in Patients with Uremia

Evaluation of Early Left Ventricular Systolic Function in Uremia Patients on Dialysis by Automated Cardiac Motion Quantification

Study on abdominal aortic wall motion in patients with end-stage renal disease by tissue Doppler imaging

A Study of Diastolic Function of Left Ventricular in CAD Patients during Dobutamine Infusion using Doppler Tissue Imaging

Cardiac structure and function in end-stage diabetic nephropathy patients

Left Heart Construction and Function in Diabetic Nephropathy: an Echocardiographic Study

Structural and functional changes of the heart in patients with diabetic nephropathy undergoing hemodialysis

The Tei index of the ventricular function of the patients with diabetic nephropathy by tissue Doppler imaging

Assessment of Ventricular Function by Pulsed Doppler Tissue Imging in Patients with Chronic Renal Failure

Ultrasonography Combined with Blood Biochemistry on the Early Diagnosis of Diabetic Kidney Disease

Cardiovascular Disease and Echocardiographic Characteristics in Patients Starting Peritoneal Dialysis

Role of Renal Artery Doppler Ultrasonography in the Evaluation of Function of Transplanted Kidney

Doppler parameters in renal transplant dysfunction: correlations with histopathologic changes

Application Value of Conventional Ultrasound Combined with Shear Wave Elastography in Diagnosing Renal Fibrosis in Diabetic Nephropathy

Impact of Diabetic Nephropathy on Pulmonary Function and Clinical Outcomes

Assessment of Renal Perfusion with Contrast-Enhanced Ultrasound: Preliminary Results in Early Diabetic Nephropathies

Prostaglandin E1 in treatment of patients with early diabetic nephropathy

2D-Speckle Tracking Echocardiography Contributes to Early Identification of Impaired Left Ventricular Myocardial Function in Patients with Chronic Kidney Disease